Clinical Trial Update: Hippocampal Sparing Whole Brain Radiotherapy vs Conventional Whole Brain Radiotherapy in Patients With Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial comparing hippocampal-sparing whole brain radiotherapy to conventional whole brain radiotherapy for brain metastases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Snippet

Sponsor: University College, London | Conditions: Brain Metastases | Phase 2 | Status: COMPLETED